MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Conduritol B epoxide

CAS No. : 6090-95-5

MCE 站：Conduritol B epoxide

产品活性：Conduritol B epoxide 是一种不可逆的，共价的 β-glucosidase 抑制剂。

研究领域：Metabolic Enzyme/Protease

作用靶点：Glucosidase

In Vitro: Treating N2a and Conduritol B epoxide-N2a cells with G6 gave GC reductions to 7% and 26% of untreated levels, respectively. G6 treated Conduritol B epoxide-N2a also has significantly decreased GS. Co-treatment of G6 and dantrolene of Conduritol B epoxide-N2a cells lead to a similar degree of GC and GS reduction as G6 alone, indicating a specific effect of G6 on inhibition of substrate accumulation, Conduritol B epoxide-N2a cells have higher calcium levels than in N2a cells without caffeine at baseline. Conduritol B epoxide-N2a cells show a significant increase in cytosolic calcium levels compared to N2a cells. Conduritol B epoxide-N2a cells show a significant reduction in OCR as evidenced by approximately 50% in all the parameters, including rate of ATP production, basal respiration, and maximal respiration, compared to N2a cells, indicating reduced mitochondrial function in this nGD cell model. In dantrolene-treated Conduritol B epoxide-N2a cells, levels of Ryr3 are increased to 76% of WT level.

In Vivo: Conduritol B epoxide treatment of 4L, 9H, 9V and WT mice (100 mg/kg/day, i.p.) from postnatal day 5 to 11 does not induce α-synuclein aggregates. Long-term daily Conduritol B epoxide treatment of 4L mice (100 mg/kg/day of Conduritol B epoxide from postnatal day 15 for 24 or 36 doses) leads to hind limb paralysis and small amounts of α-synuclein accumulation in the olfactory bulb, brainstem, and PVP near D3V (dorsal 3rd ventricle).

相关产品：Covalent Screening Library Plus  |  Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Covalent Screening Library  |  Glycoside Compound Library  |  Acarbose  |  Castanospermine  |  1-Deoxynojirimycin  |  Ambroxol  |  3,4-Dicaffeoylquinic acid  |  Celgosivir hydrochloride  |  Hexylresorcinol  |  Voglibose  |  Licochalcone C  |  Rebaudioside A  |  (+)-Afzelechin  |  Afegostat D-Tartrate  |  Naringinase  |  Oroxin A  |  Kaempferol-7-O-rhamnoside  |  Kushenol A  |  4',5-Dihydroxyflavone  |  Brevifolincarboxylic acid  |  Cedryl acetate  |  N-Nonyldeoxynojirimycin  |  Terphenyllin  |  Bisabolone oxide A  |  Butyl isobutyl phthalate  |  Chrysophanol triglucoside  |  Eleutherol  |  Ganoderic acid Y

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。